The bacterial cytolethal distending toxin (CDT) was previously shown to arrest the tumor-derived HeLa cell line in the G2-phase of the cell cycle through inactivation of CDK1, a cyclin-dependent kinase whose state of activation determines entry into mitosis. We have analysed the eects induced in HeLa cells by CDT, in comparison to those induced by etoposide, a prototype anti-tumoral agent that triggers a G2 cell cycle checkpoint by inducing DNA damage. Both CDT and etoposide inhibit cell proliferation and induces the formation of enlarged mononucleated cells blocked in G2. In both cases, CDK1 from arrested cells could be reactivated both in vitro by dephosphorylation by recombinant Cdc25B phosphatase and in vivo by caeine. However, the cell cycle arrest triggered by CDT, unlike etoposide, did not originate from DNA strand breaks as demonstrated in the single cell gel electrophoresis assay and by the absence of slowing down of S phase in synchronized cells. Together with additional observations on synchronized HeLa cells, our results suggest that CDT triggers a G2 cell cycle checkpoint that is initiated during DNA replication and that is independent of DNA damage.
Introduction
Cytolethal distending toxins (CDT) constitute a family of bacterial protein toxins, produced by various bacterial species of medical relevance, that inhibit the proliferation of several mammalian cell lines by inducing a block in the G2 phase of the cell cycle . The G2 block caused by CDT is associated with the maintenance of CDK1, a cyclindependent-kinase that determines entry into mitosis, in an inactive tyrosine phosphorylated state (Comayras et al., 1997; Whitehouse et al., 1998; Cortes-Bratti et al., 1999) . The CDT-induced G2 arrest through inactivation of CDK1 is original for a bacterial product. It is reminiscent of the mode of action of DNA-damaging agents that activate a cycle checkpoint in G2 called the DNA damage cascade (Poon et al., 1997b) .
Cell cycle checkpoints are regulatory cascades, highly conserved in eukaryotic cells, that control the order and timing of cell cycle transitions and ensure that critical events such as DNA replication and chromosome segregation are completed with high ®delity (Elledge et al., 1996; Paulovitch et al., 1997) . Activation of the DNA damage checkpoint can result in a G1 block, a slowdown of S phase, and a G2 block. Dierent components of the complex biochemical pathway leading to the G2 block following DNA damage in mammalian cells have been recently identi®ed (Peng et al., 1997; Sanchez et al., 1997) . In a current working model, the protein kinase Chk1 is activated upon DNA damage, through a pathway that is dependent upon ATM and ATR (mammalian homologues of the ®ssion yeast Rad3). Activated Chk1 has been shown to phosphorylate the phosphatase Cdc25 on Ser 216 which then binds to and might be sequestered by 14 ± 3 ± 3 protein. Thus Cdc25 would be prevented from activating CDK1 by dephosphorylation of its Tyr 15 residue. CDK1 is thus maintained in an active hyperphosphorylated state, which prevents cells from entering into mitosis.
The analogy between the anti-proliferative eect of CDT and that of DNA-damaging agents suggests that CDT could also trigger the DNA damage cascade, either by generating DNA strand breaks itself or by intervening downstream. In the present study, we have compared the eects induced by CDT and by etoposide (VP-16), a DNA damaging agent acting through inhibition of DNA topoisomerase II (Liu, 1989) . This agent was preferred to radiomimetic drugs or other DNA-damaging agents for the purpose of comparison because it induces an irreversible block in G2 associated with inactivation of CDK1 by tyrosine phosphorylation and without a persistent decrease in cyclin B1 (Maity et al., 1997) , speci®c features also observed in CDT-treated cells (Comayras et al., 1997) . We have gathered experimental evidence showing that, in spite of striking similarities between the eects induced by the two agents on HeLa cells, the G2 cell cycle arrest triggered by CDT cannot be attributable to DNA damage. More likely, it could be due to the activation of a G2 cell cycle checkpoint induced in S phase, through a signal transduction pathway that remains to be elucidated.
Results

CDT and etoposide produce a G2 cell cycle arrest and similar delayed eects in HeLa cells
Asynchronous HeLa cells were exposed for 1 h to CDT or to etoposide at 378C, according to a dose-response protocol. Cells were then followed up daily during a period of 7 days. Both products inhibited cell proliferation by blocking cells at stage G2 of the cell cycle ( Figure 1a ). Arrested cells grew progressively in size, taking the aspect of giant mononucleated cells, with a diameter 5 ± 10-fold larger than that of control cells after 4 days of incubation. The morphological aspect of cells blocked by CDT or etoposide was not dierent (Figure 1c ). The toxic activity was de®ned as the lower cytopathic dose which caused 100% of enlarged cells after 72 h of incubation (CD100). For etoposide, this dose corresponded to 50 mM of the product. With one CD100 of either agent, more than 90% of the exposed cells were irreversibly blocked at stage G2/M 24 h after exposure as observed in¯ow cytometric analysis (Figure 1a ). Up to 24 h after exposition, cells were considered as strictly blocked in G2 with both agents, as ®gures of mitosis were observed in less than 1% of cells. With lower doses, the block observed 24 h after exposure was partial and dose-related. In cells treated with 1 CD100 of either agent, lethality started about 2 days after exposure, resulting in about 50% survival 3 days after exposure and about 20% 4 days after exposure (Figure 1b) .
In cells blocked in G2 by CDT, CDK1 can be reactivated in vitro by recombinant Cdc25B phosphatase A major CDK1 activating event at the G2/M boundary is the dephosphorylation of critical tyrosine residue located at position 15 within the ATP binding site. This reaction is catalyzed by the evolutionary conserved Cdc25 dual speci®city phosphatase (Gabrielli, 1994) . We hypothesized that the low level of CDK1 catalytic activity in cells blocked in G2 was due Figure 1 CDT and etoposide produce similar early and delayed eects in HeLa cells. (a) Induction of a G2/M block by CDT and etoposide in asynchronous HeLa cells. Cell distribution according to DNA content of nuclei suspensions was analysed, 24 h after exposure to 1 CD100, by¯ow cytometry after staining of DNA with PI. About 10 000 nuclei were analysed by sample. In each case, the G1 peak was arbitrarily centered at channel 200. (b) Kinetics of survival in HeLa cells exposed to 1 CD100 of CDT or etoposide (50 mM) for 1 h. After methylene blue staining, cells were counted on 10 successive microscope ®elds (error bars indicate standard errors). Cell viability is the percentage of remaining cells remaining over cells present before exposure to agents. (c) Induction of morphological alterations in HeLa cells both by CDT and etoposide, 4 days after exposure to 1 CD100, as compared with cells at time of exposure. Methylene blue staining. All images are of same magni®cation. Note the formation of giant mononucleated cells with large nuclei due to both agents G2 checkpoint activated by CDT V Sert et al to the lack of tyrosine 15 dephosphorylation. To examine this hypothesis we puri®ed CDK1/cyclin B kinase complexes from HeLa cells extracts using p13
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Sepharose beads as an anity matrix and tested whether the enzyme could be activated in vitro using recombinant Cdc25B phosphatase. As shown in Figure  2 , the catalytic activity of CDK1 from HeLa cells treated with CDT or etoposide was very low, in agreement with previous reports (Comayras et al., 1997; Lock et al., 1994) . Western blot with anti-CDK1 antibodies indicated that the largest fraction of the CDK1 protein migrated as a low electrophoretic mobility band which is known to be tyrosine phosphorylated. Upon incubation with Cdc25B, the CDK1 kinase activity was found to be largely increased (about 50-fold for CDT treated cells) (Figure 2a) . Accordingly, Western blots con®rmed that CDK1 was fully converted to its faster electrophoretic mobility form that is not phosphorylated on tyrosine 15 ( Figure  2b ). These results show that with both CDT and etoposide, dephosphorylation of Tyr 15 residue was sucient to fully activate CDK1, in other terms that, in both cases, phosphorylation of CDK1 on Tyr-15 could totally account for the inactive state of CDK1. As inactivation of CDK1 was the ultimate step of the DNA damage cascade leading to the G2 block induced . Top: validation of the method through the comparison of control asynchronous cells (left) and cells exposed for 8 h to 100 nM of nocodazole, a drug reported to arrest cells in prometaphasis (right). Below: cell cycle distribution in cells exposed to CDT, 24 h after exposition (left) and in cells exposed to CDT then immediately treated for 24 h with caeine (2 mM). G1 and M populations were gated as shown and their proportion over the total population was counted using the statistical CellQuest software. About 10 000 events were recorded. (b and c) Eect of graded doses of caeine on G2 block alleviation. Caeine was added to HeLa cell cultures immediately after exposure to 1 CD100 of agent for 24 h (b), or 24 h after exposure (i.e. on cells already arrested in G2) for 6 h (c). For each type of protocol, the results of a representative experiment are shown G2 checkpoint activated by CDT V Sert et al by etoposide, we speculated that CDT could active a similar checkpoint mechanism.
CDT and etoposide-mediated G2 block can be alleviated by caeine
Methylxanthines, such as caeine and pentoxifylline, are known to partially reverse the arrest in G2 caused by several DNA-damaging agents (Poon et al., 1997b) , in particular in HeLa cells exposed to etoposide (Lock et al., 1994; Barratt et al., 1998) . To substantiate the hypothesis that CDT was able to trigger the DNA damage cascade, we tested the ability of caeine to alleviate the G2 block caused by CDT. Caeine was applied either just after drug exposure during a prolonged period of time (24 h), or on cells already blocked in G2 during a shorter period of time (6 h). The former protocol tested the ability of caeine to prevent installation of the block, whereas the latter tested its ability to push arrested cells into cycling. Cell cycle distribution was analysed by¯ow cytometry after staining of DNA with propidium iodide and of mitotic epitopes with a monoclonal antibody against mitotic phosphoproteins (MPM-2) (Barratt et al., 1998; Friedrich et al., 1998) . As illustrated in Figure 3a , this method was highly eective in distinguishing cells in G2 from cells in M, allowing a reliable assessment of the proportion of cells pushed in M and G1 by caeine. Results of a representative experiment of each protocol is shown in Figure 3b and c. When applied immediately after exposure to CDT (Figure 3b ), 1 mM of caeine triggers the passage of more than 20% of cells to G1, a proportion that increased to a maximum of about 30% with 2 or 3 mM of the drug. These ®gures were of the same order of magnitude than those obtained in etoposide-treated cells, except that caeine eect appeared more gradually dose-related in cells exposed to the latter drug, with a maximum of about 50% of cells in G1 with 3 mM of caeine. When caeine was applied after establishment of either drug (Figure 3c ), the cells were more resistant to this eect. Only a small proportion of them were able to reach G1 after 6 h of caeine treatment, and a large proportion of those that exited G2 remained arrested in M. The proportion of S phase progression in synchronized HeLa cells exposed to CDT or etoposide. HeLa cells were synchronized at the G1/S border by the double thymidine block method. One hour after release from G1/S (early S), they were exposed for 1 h to 1 CD100 of etoposide or CDT. Distribution of cells according to DNA content was analysed by¯ow cytometry 3, 6, 9 and 24 h after release from G 1 /S. About 10 000 nuclei were analysed by sample. In each case, the G1 peak arbitrarily centered at channel 200. The horizontal bar materializes the distance between cells blocked in G1/S and cells progressing in S. In contrast to etoposide, CDT did not slow down progression through S phase G2 checkpoint activated by CDT V Sert et al cells in M increased with caeine concentration, reaching about 15 and 10%, in CDT-and etoposideexposed cells, respectively, with 3 mM of caeine. These ®gures were similar upon repetition of the experiments.
CDT does not induce detectable strand-breaks in HeLa cells
All the preceding results converged to the hypothesis that CDT was able to activate the DNA damage cascade, possibly by inducing DNA strand breaks. The occurrence of early DNA strand breaks in cells exposed to CDT was investigated by using the single cell gel electrophoresis assay, also called the`comet assay'. This test was used in alkaline conditions, a procedure previously reported to detect both single and double strand breaks (Singh et al., 1988; Olive et al., 1990) . As expected, etoposide produced DNA strand breaks according to a dose-related response ( Figure  4b ). The minimal dose of etoposide able to induce detectable strand breaks after 1 h of exposure was estimated at about 1/10 of CD100, i.e. 5 mM. In contrast, no detectable lesions were observed with control preparations nor with CDT with doses up to 10 CD100 applied during 1 h (Figure 4a ). To take into account a possible delay in any DNA-damaging eect of CDT, we performed the comet assay in HeLa cells exposed for 2, 3 and 4 h with 1 and 10 CD100, and for 16 h with 2 CD100. Again, no comets were detectable in these conditions (data not shown).
CDT does not slow down S phase
In addition to a G2 checkpoint control, DNA strand breaks are known to activate another checkpoint control that results in the slowing down of S phase. We then compared the rate of progression through S phase of synchronized HeLa cells exposed to CDT or to etoposide. To this end, HeLa cells were synchronized in G1/S by the double-thymidine block method and exposed to 1 CD100 of either agent, in early S phase. Progression into the cell cycle was by then followed-up by¯ow cytometry over a 24 h period of time. As shown in Figure 5 , CDT-exposed cells progressed through the S phase at the same rate than control cells. In contrast, etoposide-exposed cells were considerably slowed down, their rate of progression being roughly half that of control cells. Nine hours after G1/S release, about 80% of CDT-exposed cells were blocked in G2, whereas most of the cells exposed to etoposide were still in S. Twenty-four hours after release from G1/S, etoposide-exposed cells were then eventually blocked in G2 ( Figure 5 ). Thus the lack of eect of CDT on S phase progression strengthened our observations in the comet assay where CDT did not cause early DNA damage.
The G2 checkpoint triggered by CDT cannot be induced in G2-phase
The above results implied that the G2 checkpoint control induced by CDT was unlikely initiated by DNA damage. One alternate possibility was that CDT was able to activate a G2 checkpoint control activated only during S phase (Elledge, 1996; Stillman, 1996; Paulovich et al., 1997) . Such an hypothesis was compatible with our previously published observation that HeLa cells exposed to CDT in G2 were not blocked in the current cycle but only at the subsequent one (Comayras et al., 1997) . We then compared the progression through the cell cycle of cells exposed in G2 to etoposide or to CDT. Cells synchronized in G1/S by double thymidine block were exposed for 1 h to 1 CD100 of CDT or etoposide 8 h after release from G1/S, that is roughly in early G2 phase. Whereas cells exposed to etoposide did not go past the current G2 phase, more than 90% of the cells exposed to CDT entered a new cycle to eventually arrest in the next G2 phase (Figure 6 ). Etoposide, in contrast to CDT, was therefore able to trigger the G2 checkpoint when applied in the G2 phase.
Discussion
Our aim was to investigate the molecular basis of the antiproliferative eects of CDT bacterial toxins. This objective was justi®ed by the fact that CDT causes in HeLa cells a speci®c arrest at the G2/M border that is associated with the inactivation of CDK1 by hyperphosphorylation (Comayras et al., 1997; Whitehouse et al., 1998; Cortes-Bratti et al., 1999) . The possible analogy between CDT and a prototype DNA-damaging agent, Figure 6 Cell cycle progression in cells exposed to CDT or etoposide during G2. HeLa cells were synchronized at the G 1 /S border by the double thymidine block method. Eight hours after release from G 1 /S (early G 2 ), they were exposed for 1 h to 1 CD100 of etoposide or CDT. Distribution of cells according to DNA content was analysed by¯ow cytometry 13, 24 and 32 h after time of release from G 1 /S (i.e. 4, 15 and 23 h after the end of exposure to agent). About 10 000 nuclei were analysed by sample. In each case, the G1 peak was arbitrarily centered at channel 200. Whereas cells exposed to etoposide arrested in G2 of the current cycle, cells exposed to CDT arrested at subsequent G2 G2 checkpoint activated by CDT V Sert et al etoposide, whose early eects on HeLa cells had been studied before (Lock and Killing, 1993; Lock et al., 1994) led us to analyse in detail and comparatively the properties of these agents. The similarity of action suggested that CDT might eventually induce in eukaryotic cells the activation of a physiological G2 checkpoint that is normally activated by agents causing DNA strand breaks (Poon et al., 1997b) . The preliminary step was to verify if the cytological eects induced by etoposide and CDT in HeLa cells were comparable (Figure 1) . We showed that both agents induce a dose-related arrest of cell proliferation associated with a G2 block and the progressive swelling of blocked cells. With 1 CD100 of either product death is not signi®cant during at least the ®rst 24 h after exposure but increases dramatically after 48 h. Moreover, cytometry analysis shows that in both cases cell death results principally from multipolar abortive mitosis starting from 2 days after exposure (manuscript in preparation). This apparent similarity in both early and delayed cytological events are probably the consequences of the sustained G2 block itself. It also implies that CDT does not induce other detectable cytological alterations than those produced by etoposide at least in the experimental conditions used in this study.
The immediate upstream signaling events leading to the G2 block itself also appeared identical in cells exposed to CDT or to eposide. In both cases in vitro reactivation of CDK2 from arrested cells could be obtained directly through dephosphorylation of the Tyr-15 residue by recombinant Cdc25B phosphatase. The magnitude of CDK1 reactivation was comparable and dramatically elevated in both cases (about 50-fold increase with CDT) (Figure 2 ). This observation suggests that phosphorylation of CDK1 on Tyr-15 was the major speci®c event accounting for its inactivation in vivo.
At this stage of our study it was therefore legitimate to assume that CDT was activating the DNA damage cascade, which is known to be activated by etoposide as well as by other DNA-damaging agents (Lock, 1992; Ye et al., 1996; Poon et al., 1997b; Kaufman and Kies, 1998) . To further investigate the possible implication of the DNA damage cascade we have studied the eect of caeine on the block. Caeine is known to overcome the G2 checkpoint control related to DNA damage (Lau and Pardee, 1982; Fingert et al., 1986; Lock et al., 1994; Poon et al., 1997b; Barratt et al., 1998) or to replication (Schlegel et al., 1986; Downes et al., 1990) . How caeine is able to disrupt these checkpoint pathways is not yet fully understood but recent observations on Xenopus eggs suggest that caeine could abolish the phosphorylation of Chk1, thus preventing the phosphorylation of Cdc25C on Ser-287 residue. The lack of phosphorylation of Cdc25C prevents its sequestration by 14 ± 3 ± 3 proteins, thus allowing the activation of CDK1 (Kumagai et al., 1998) .
Caeine was able to partially overcome the block caused by CDT, with an order of magnitude roughly similar to that observed with cells exposed to etoposide. We observed that complete passage from G2 to G1 was fully eective only when caeine was applied immediately after exposure to the blocking agent. In contrast, when caeine was applied after installation of the block, a signi®cant proportion of cells were induced to express the MPM-2 epitopes but seldom resumed cell cycle progression by reaching the G1 phase. The dierence observed between the results of the two protocols could mean that caeine is able to prevent the G2 block in a signi®cant proportion of cells but is not eective in inducing cycle progression in cells that are already blocked. With etoposide, our results are in overall good agreement with two previous studies on HeLa cells exposed to etoposide (Lock et al., 1994; Barratt et al., 1998) . Although experimental settings are not strictly comparable, the latter studies show that 1 or 2 mM of caeine applied immediately after exposure to etoposide caused a signi®cant mitotic progression and, in a variable proportion of cells, entry into the G1 phase. In both studies block alleviation was associated with a signi®cant activation of CDK1. In the study of Barratt et al. (1998) , caeine was much more ecient in alleviating the G2 block caused by X-ray than that caused by etoposide, an observation which suggested the existence of a caeineinsensitive component in the G2 checkpoint activated by etoposide. The higher resistance of etoposideinduced block to caeine alleviation is possibly mechanistically linked to the irreversible nature of this block, as compared to the transient nature of Xray-induced block (Poon et al., 1997a) . In etoposidetreated cells, caeine resistance may be related to the inability of cells to undergo normal chromosome condensation, an event that required the participation of DNA topoisomerase IIa (Munoz et al., 1998) . In CDT-arrested cells the nature of this caeineinsensitive component should be investigated further.
At this stage of the study, we could therefore speculate that the activation by CDT of at least some components of the DNA damage cascade was caused by the induction of early DNA strand breaks. This hypothesis was ruled out by the absence of detectable strand breaks in the comet assay (Figure 4 ) and by the fact that CDT, in contrast to etoposide, did not interfere with the progression of cells through S phase ( Figure 5 ). The comet assay under alkaline conditions is reported to allow the detection of both single and double strand breaks (Singh et al., 1988; Olive et al., 1990) . Compared to other available tests, it allows microscopic individual cell evaluation of DNA damage and, following image analysis, lends itself to quantitative measurement using the tail moment criterion. According to our results, the minimal concentration of etoposide applied for 1 h able to cause detectable DNA strand breaks was estimated to be around 5 mM, i.e. approximately 1/10 of the CD100 (Figure 4 ). This result is in good agreement with previous estimations obtained with the same agent using either alkaline elution assay (Wozniak and Ross, 1983; Long et al., 1984) or pulse-®eld gel electrophoresis (Vock et al., 1998) . In the same conditions, 10 CD100 of CDT did not induce detectable DNA strand breaks, nor did the prolonged exposure of the cells to the toxin (up to 16 h). This means that CDT does not induce early strand breaks in HeLa cells and, consequently, that formation of early strand breaks does not constitute the primary event triggering the G2 checkpoint induced by CDT. The fact that CDT, in contrast to etoposide, does not interfere with the progression of cells through S phase (Figure 5 ) probably re¯ects the absence of primary DNA damage. As observed in this study with G2 checkpoint activated by CDT V Sert et al etoposide, DNA damage or abnormal DNA replication also leads to decreased rate of on-going DNA synthesis (Paulovich et al., 1997) .
The fact that CDT does not cause early detectable DNA strand breaks points to a major dierence with etoposide. CDT, in contrast to etoposide, would not lead to the activation of the DNA damage cascade sensu stricto but would induce another G2 checkpoint control that also maintains CDK1 in an inactive phosphorylated state. The behavior of synchronized cells exposed in G2 to CDT or etoposide may provide a clue to the nature of this possible G2 checkpoint control (Figure 6 ). In contrast to etoposide-treated cells, cells exposed to CDT in G2 are unable to induce the checkpoint in the current cycle and should enter another cycle to induce it. We had shown previously that synchronized HeLa cells exposed to CDT during S phase were blocked in the G2 phase of the current cycle (Comayras et al., 1997) . These observations could mean that CDT induces a G2 checkpoint control that is normally activated during S phase, such as a replication checkpoint. The replication checkpoint couples mitosis to completion of DNA replication and maintains CDK1 in an inactive phosphorylated form (Boddy et al., 1998) . In this regard, there might be some analogy between the mode of action of CDT and that of a viral protein, the Vpr of human immunode®ciency virus (HIV-1), which induces a G2 block in HeLa cells through inactivation of CDK1 by hyperphosphorylation (Poon et al., 1997a) . Vpr is a 11-kDa accessory protein of HIV-1 that interacts in vivo with HHR23A, a cellular protein implicated in nucleotide-excision DNA repair, and this speci®c interaction is thought to trigger the cascade leading to inactivation of CDK1 (Withers-Ward et al., 1997; Gragerov et al., 1998) . Another caeine-sensitive checkpoint control speci®cally induced in S phase has also been described: the so-called topoisomerase IIdependent G2 checkpoint (Downes et al., 1994) . This checkpoint is activated by inhibitors of topoisomerase II such as ICRF-193, which inhibits chromatid decatenation without damaging DNA (Kaufman and Kies, 1998; Munoz et al., 1998) . Like CDT, ICRF-193 does not seem to interfere with cell progression through S phase (Ishida et al., 1994) . This analogy between CDT and ICRF-193 could be investigated further by testing the possible consequences of CDT exposure on topoisomerase II activity or, more generally, on the replication process. Alternatively, the ability of cells exposed in G2 to induce the checkpoint in the current cycle might be related to the delay required for toxin processing in the target cells and completion of its speci®c signalization pathway. This hypothesis appears however unlikely since cells were exposed in early G2, i.e. about 3 h before their estimated average entry time into mitosis.
Even if the ultimate CDT-triggered signalization leading to CDK1 inactivation has a nuclear origin, it does not imply necessarily that the initial target of CDT is nuclear. As with many protein bacterial toxins, the uptake and processing of CDT by mammalian cells is most probably a complex process including binding to a cell surface receptor, internalization by endocytosis and entering the cytoplasm (Saelinger, 1990) . The overall pathway that leads to the induction of the G2 checkpoint by CDT is probably not as straightforward as that of non-protein molecules such as DNAdamaging agents that directly target a nuclear molecule or function. The complete unraveling of the mode of action of CDT on mammalian cells, besides its interest in the ®eld of bacterial toxicology, could provide original insights on the control of cellular proliferation.
Materials and methods
Determination of CDT and etoposide cytotoxic endpoints CDT was produced from E. coli DH5-a hosting recombinant plasmid pDS 7.96, which contains the three open reading frames (cdtA, cdtB and cdtC) necessary to encode CDT activity (Scott and Kaper, 1994) . The toxic preparation consisted in the sterile supernatant of a 24 h trypticase soy broth aerated culture of this recombinant strains and the control non-toxic preparation was a supernatant of strain DH5-a hosting the same plasmid without insert (pKSII), as previously described (Comayras et al., 1997) . Etoposide was purchased from Sigma and stock solutions were made in DMSO. For each agent, the 100% cytopathic dose (CD100) was de®ned as the highest dilution which, following a 1 h application on HeLa cell cultures at 378C, gave 100% elongated cells after 72 h of incubation (PeÂ reÁ s et al., 1997).
In the text,`control cells' refers to cells exposed to control preparations.
Quanti®cation of cell viability
HeLa cells (ATCC CCL2) were grown at 378C in Eagle minimal essential medium with Earle's salt (MEME) (Gibco± BRL), L-glutamine (200 mM) (Gibco±BRL) and 10% fetal calf serum (Gibco±BRL) in a 5% CO 2 atmosphere. For the assay of cell viability (Figure 1 ), non con¯uent asynchronous HeLa cells exposed during 1 h to 1 CD100 of CDT or etoposide at 378C were cultured up to 7 days after exposure. At speci®ed times, cell cultures were washed in Hank's buered saline solution (HBSS), ®xed in 1% formaldehyde in HBSS at least for 30 min at room temperature and then stained with a 1% (wt/vol) solution of methylene blue in 10 mM borate buer (pH 7.4) for 30 min. Each day, the number of adherent viable cells in 10 successive microscope ®elds was determined. For each time point, cell viability was expressed as the per cent ratio of remaining viable cells over initial count.
Flow cytometric analysis
Cell cycle distribution was assessed using nuclear suspensions made directly from adherent cell cultures with an extractionstaining 0.1% sodium citrate buer containing Nonidet P40 (0.9%) and propidium iodide (40 mg/ml, Sigma) for 30 min at 48C in the dark. Flow cytometric analysis was performed on a FACScalibur¯ow cytometer (Becton Dickinson), using the red (PI) emission (630 nm) for DNA quanti®cation. The data from 10 4 nuclei were collected and analysed by using CellQuest software (Becton Dickinson).
Mitotic MPM-2 antigens were stained by an indirect immuno¯uorescence technique including brie¯y: (i) ®xation and permeabilization of washed trypsinized cells in cold methanol, (ii) incubation in MPM-2 monoclonal antibody No. 2 (Upstate Biotechnology) during 3 h at room temperature (10 mg/ml in PBS), washing in PBS; and (iii) incubation for 1 h in the dark at room temperature with a FITC-conjugated goat antimouse antibody (Sigma). After washing, cells were suspended in¯ow cytometric analysis DNA staining solution containing propidium iodide (10 mg/ ml) and RNAse (1 mg/ml) in PBS.
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Flow cytometric analysis was performed on a FACScalibur¯ow cytometer (Becton Dickinson), using the FL1 channel for FITC quanti®cation and the FL2 channel for DNA quanti®cation (propidium iodide). The data from 10 4 nuclei were collected and analysed by using CellQuest software (Becton Dickinson).
In vitro reactivation assay of CDK1 kinase activity by recombinant Cdc25B phosphatase HeLa cells were lysed as described previously (Comayras et al., 1997) in a 50 mM HEPES buer (pH 7.4) containing Triton X-100 (0.1%), NaCl (150 mM), MgCl 2 (15 mM), bglycerophosphate (50 mM), dithiothreitol (1 mM), EGTA (20 mM), NaF (25 mM), and protease inhibitor cocktail (Complete, Boehringer). Anity chromatography on p13 suc1 Sepharose beads was used to recover the CDK1/cyclin B complexes. P13 Sepharose beads were prepared according to Brizuela et al. (1987) . A 20 ml volume of beads were incubated with 200 mg of cell lysate for 3 h at 48C on a rotator in 1 ml ®nal volume of lysis buer (50 mM Tris HCl pH 7.5, 250 mM NaCl, 5 mM EDTA, 0.1% Triton X100, 1 mM dithiothreitol (DTT) supplemented with protease inhibitors (1 mg/ml leupeptin, 1 mg/ml aprotinine, 10 mg/ml soybean trypsin inhibitor, 10 mg/ml tosyl lysine chloromethyl ketone (TLCK), 10 mg/ml tosyl phenylalanine chloromethyl ketone (TPCK), 0.17 mg/ml phenyl methyl sulfonyl¯uoride (PMSF) and phosphatases inhibitors (50 mM NaF, 0.1 mM Na 3 VO 4 , 10 mM b-glycerophosphate). P13 Sepharose precipitates were washed three times in lysis buer without phosphatase inhibitors and once in phosphatase buer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 1 mM EDTA, 1 mM DTT). P13 Sepharose precipitates were then incubated or not with 3 mg of recombinant GST-CDC25B1 produced and puri®ed as already described (Baldin et al., 1997) , for 1 h at 308C in 50 ml phosphatase buer with gentle mix every 5 min. The p13 Sepharose precipitates were then washed once in kinase buer (50 mM Tris HCl pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 100 mM ATP) and assayed for kinase activity in a 30 ml volume of kinase buer containing 0.5 mg/ml histone H1 (Boehringer) as substrate and 5 mCi of [g-32 P]ATP (NEN), 5 min at 308C. After SDS ± PAGE electrophoresis of the reaction mix, H1 histone bands were excised from the gel and counted in a Packard 16500 TR counter (Cerenkov eect). Western blot analyses were performed essentially as described (Baldin et al., 1997) using polyclonal antibodies against CDK1 (Santa Cruz).
DNA damage measured using the alkaline single cell gel electrophoresis (Comet) assay Comet assays were performed according to Singh et al. (1988) with slight modi®cations. After treatment in the conditions speci®ed in Results, HeLa cells were trypsinized. Immediately, about 3.6610 4 cells were embedded in 1 ml of low melting agarose (1% in distilled water) which was layered onto microscope slides. After solidi®cation of agarose, slides were immersed in cold lysing solution (1% sodium sarcosinate, 2.5 M NaCl, 100 mM Na 2 -EDTA, 10 mM Tris, pH adjusted to 10 and 1% Triton X-100) for 1 h at least, at 48C. Then, slides were removed from lysing solution, gently rinsed with distilled water and placed on a horizontal gel electrophoresis unit (Biorad). The unit was ®lled with freshly made alkaline buer (1 mM Na 2 -EDTA, 300 mM NaOH, pH412.5). The slides remained immersed in the buer for 20 min. Electrophoresis was carried out in the same buer for 20 min at 0.66 V/cm. Slides were then gently washed with 0.4 M Tris at pH 7.4 and DNA was stained by adding 2 ml of propidium iodide (PI) (Sigma) at 2.5 mg/mL for 10 min at room temperature in the dark. Slides were gently rinsed and observed with epi¯uorescent microscope (Leica) with a Zeiss 206¯uorescence objective lens. Photographs were taken using Kodak 400 ASA color 35 mm ®lm.
To quantify the level of DNA damage in each cell, photos were scanned on an Omni media Scanner XRS 12 cx (Bioimage, MI, USA). For each comet, intensity of DNA in the head and tail regions (after background correction), and distance between the means of the head and tail DNA distributions (in pixels), were determined using 2D Analyser software (Bioimage) on a Sun Sparc Station 5 (Cadrus, France). About 40 comets were analysed for each dose point. No attempt was made to select comets, other than to avoid obvious debris or comets spaced too closely together. Tail moment accounts for DNA damage. It was de®ned as the product of the percentage of DNA in the comet tail and of the distance between the means of the head and tail DNA distributions (Olive et al., 1990) .
Cell synchronization
Synchronization at the G1/S border was performed on non con¯uent HeLa cell cultures by the double thymidine block (DTB) method (Knehr et al., 1995) . After 8 h of incubation, cells were in G2. Synchronization in mitosis (prometaphase) was performed by culture in the presence of nocodazole (100 nM) for 16 h.
